Synthesized OVA(323-339)MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

BACKGROUND: Antigen-specific immunotherapy (SIT) has been widely practiced in treating allergic diseases such as asthma. However, this therapy may induce a series of allergic adverse events during treatment. Peptide immunotherapy (PIT) was explored to overcome these disadvantages. We confirmed that...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Su, Wen, Zhong, Wenwei, Zhang, Yanjie, Xia, Zhenwei
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2012
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472185/
https://ncbi.nlm.nih.gov/pubmed/22769043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2172-13-34
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk